Milota T - Search Results

1

Encapsulation: A Strategy to Deliver Therapeutics and Bioactive Compounds?

Klojdová I, Milota T, Smetanová J, Stathopoulos C. Klojdová I, et al. Among authors: milota t. Pharmaceuticals (Basel). 2023 Feb 27;16(3):362. doi: 10.3390/ph16030362. Pharmaceuticals (Basel). 2023. PMID: 36986462 Free PMC article. Review.

2

Novel XIAP mutation causing enhanced spontaneous apoptosis and disturbed NOD2 signalling in a patient with atypical adult-onset Crohn's disease.

Parackova Z, Milota T, Vrabcova P, Smetanova J, Svaton M, Freiberger T, Kanderova V, Sediva A. Parackova Z, et al. Among authors: milota t. Cell Death Dis. 2020 Jun 8;11(6):430. doi: 10.1038/s41419-020-2652-4. Cell Death Dis. 2020. PMID: 32514016 Free PMC article.

3

Principles and new perspectives in the vaccination against SARS-CoV-2 virus.

Smetanová J, Střížová Z, Bartůňková J, Milota T. Smetanová J, et al. Among authors: milota t. Cas Lek Cesk. 2020 Winter;159(7-8):298-302. Cas Lek Cesk. 2020. PMID: 33445936 Review. English.

4

Principles and Challenges in anti-COVID-19 Vaccine Development.

Strizova Z, Smetanova J, Bartunkova J, Milota T. Strizova Z, et al. Among authors: milota t. Int Arch Allergy Immunol. 2021;182(4):339-349. doi: 10.1159/000514225. Epub 2021 Feb 1. Int Arch Allergy Immunol. 2021. PMID: 33524979 Free PMC article. Review.

5

An immunologist's perspective on anti-COVID-19 vaccines.

Milota T, Strizova Z, Smetanova J, Sediva A. Milota T, et al. Curr Opin Allergy Clin Immunol. 2021 Dec 1;21(6):545-552. doi: 10.1097/ACI.0000000000000788. Curr Opin Allergy Clin Immunol. 2021. PMID: 34545040 Review.

6

Accelerated Maturation, Exhaustion, and Senescence of T cells in 22q11.2 Deletion Syndrome.

Smetanova J, Milota T, Rataj M, Bloomfield M, Sediva A, Klocperk A. Smetanova J, et al. Among authors: milota t. J Clin Immunol. 2022 Feb;42(2):274-285. doi: 10.1007/s10875-021-01154-9. Epub 2021 Oct 29. J Clin Immunol. 2022. PMID: 34716533

7

Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab.

Smetanova J, Strizova Z, Sediva A, Milota T, Horvath R. Smetanova J, et al. Among authors: milota t. Lancet Rheumatol. 2022 Mar;4(3):e163-e166. doi: 10.1016/S2665-9913(21)00393-3. Epub 2021 Dec 21. Lancet Rheumatol. 2022. PMID: 34957418 Free PMC article. No abstract available.

8

Risk Factors for Severe COVID-19 and Hospital Admission in Patients With Inborn Errors of Immunity - Results From a Multicenter Nationwide Study.

Milota T, Sobotkova M, Smetanova J, Bloomfield M, Vydlakova J, Chovancova Z, Litzman J, Hakl R, Novak J, Malkusova I, Hanzlikova J, Jilek D, Hutyrova B, Novak V, Krcmova I, Sediva A, Kralickova P. Milota T, et al. Front Immunol. 2022 Feb 28;13:835770. doi: 10.3389/fimmu.2022.835770. eCollection 2022. Front Immunol. 2022. PMID: 35296097 Free PMC article.

9

Immunogenicity and safety of the booster BNT162b2 vaccine in patients with axial spondyloarthritis treated with biological disease-modifying drugs.

Smetanova J, Milota T, Rataj M, Hurnakova J, Zelena H, Sediva A, Horvath R. Smetanova J, et al. Among authors: milota t. Front Immunol. 2022 Sep 23;13:1010808. doi: 10.3389/fimmu.2022.1010808. eCollection 2022. Front Immunol. 2022. PMID: 36211417 Free PMC article.

10

Clinical Outcomes, Immunogenicity, and Safety of BNT162b2 Vaccine in Primary Antibody Deficiency.

Milota T, Smetanova J, Skotnicova A, Rataj M, Lastovicka J, Zelena H, Parackova Z, Fejtkova M, Kanderova V, Fronkova E, Rejlova K, Sediva A, Kalina T. Milota T, et al. J Allergy Clin Immunol Pract. 2023 Jan;11(1):306-314.e2. doi: 10.1016/j.jaip.2022.10.046. Epub 2022 Nov 13. J Allergy Clin Immunol Pract. 2023. PMID: 36379409

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page